LYTIR

Insider · SEC Form 4 · Director

Jason Aryeh

Filed with the SEC as Aryeh Jason; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $1.7M of LGND. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.7M in total.Oct: Insider sales $452KNov: Insider sales $1.3MDecJanFebMarAprMayJunJulAugSepOctNov$1.3M
Insider purchases above the line: $0Insider sales below: $1.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. LGNDSold: LIGAND PHARMACEUTICALS INC Nov 10, 2026 3,000 shares filed Nov 12, 2026 6 transactions filing $960K
  2. LGNDSold: LIGAND PHARMACEUTICALS INC Nov 4, 2026 282 shares filed Nov 6, 2026 108,476 shares held directly after, as filed filing $90K
  3. LGNDSold: LIGAND PHARMACEUTICALS INC Nov 2, 2026 700 shares filed Nov 3, 2026 108,758 shares held directly after, as filed filing $224K
  4. LGNDSold: LIGAND PHARMACEUTICALS INC Oct 30, 2026 1,411 shares filed Nov 3, 2026 5 transactions filing $452K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. LGNDAryeh Jason filed Nov 10, 2026 LIGAND PHARMACEUTICALS INC Director 3,000 shares planned sale date 11/10/2026 filing $960K
  2. LGNDAryeh Jason filed Nov 4, 2026 LIGAND PHARMACEUTICALS INC Director 282 shares planned sale date 11/04/2026 filing $90K
  3. LGNDAryeh Jason filed Nov 2, 2026 LIGAND PHARMACEUTICALS INC Director 700 shares planned sale date 11/02/2026 filing $222K
  4. LGNDJASON M ARYEH filed Oct 30, 2026 LIGAND PHARMACEUTICALS INC Director 1,209 shares planned sale date 10/30/2026 filing $385K
  5. LGNDAryeh Jason filed Oct 30, 2026 LIGAND PHARMACEUTICALS INC Director 202 shares planned sale date 10/30/2026 filing $65K